DrugPatentWatch Report Store
Showing 109–120 of 905 results
- Drug Patent Reports
BYLVAY (odevixibat) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
CABENUVA KIT (cabotegravir; rilpivirine) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
CABOMETYX (cabozantinib s-malate) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
CABTREO (adapalene; benzoyl peroxide; clindamycin phosphate) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
CALCIUM ACETATE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
CALCIUM CARBONATE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
CALCIUM CHLORIDE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
CALCIUM POLYCARBOPHIL Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
CALCIUM STEARATE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
CALCIUM SULFATE DIHYDRATE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now
